| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/28/1994 | WO1994009120A1 Retroviral mediated transfer of the human multiple drug resistance gene |
| 04/28/1994 | WO1994009056A1 Chelating polymers |
| 04/28/1994 | WO1994009025A1 Gestagenically active 19,11-bridged 4-estrenes |
| 04/28/1994 | WO1994009017A1 Pyrimidine bisphosphonate esters and (alkoxymethylphosphinyl)alkyl phosphonic acids as anti-inflammatories |
| 04/28/1994 | WO1994009014A1 Pure enantiomers of phosphoric-acid esters as phospholipase-a2 inhibitors |
| 04/28/1994 | WO1994009010A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 04/28/1994 | WO1994009009A1 3,3-disubstituted tri- and tetracyclic indolin-2-ones useful for the treatment of cognitive disorders |
| 04/28/1994 | WO1994009000A1 Quinoxalinedione derivatives as eaa antagonists |
| 04/28/1994 | WO1994008998A1 Imidazopyridine derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | WO1994008997A1 Substituted benzylaminoquinuclidines as substance p antagonists |
| 04/28/1994 | WO1994008996A1 Sulfonamide derivatives of benzenefused hydroxy substituted cycloalkyl and heterocyclic ring compounds |
| 04/28/1994 | WO1994008995A1 Heterocyclic condensed benzoic acid derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | WO1994008994A1 Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists |
| 04/28/1994 | WO1994008993A1 Benzofuran derivatives as 5-ht1-like receptor antagonists |
| 04/28/1994 | WO1994008992A1 Heterocyclic ether compounds that enhance cognitive function |
| 04/28/1994 | WO1994008990A1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders |
| 04/28/1994 | WO1994008989A1 N-arylheteroarylalkyl 1-cycloalkyl-imidazol-2-one compounds for treatment of circulatory disorders |
| 04/28/1994 | WO1994008985A1 Benzopyranones, method of preparing them and their use |
| 04/28/1994 | WO1994008984A1 Novel taxane derivatives, their preparation and pharmaceutical compositions containing them |
| 04/28/1994 | WO1994008966A1 Quinolone and acridinone derivatives for the treatment of urinary incontinence |
| 04/28/1994 | WO1994008965A1 N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists |
| 04/28/1994 | WO1994008962A1 Fibrinogen receptor antagonists |
| 04/28/1994 | WO1994008949A2 Metal-oxime chelates for use as radiopharmaceutical agents |
| 04/28/1994 | WO1994008945A1 Substituted ethanolamine esters |
| 04/28/1994 | WO1994008941A1 Arginine keto-amide enzyme inhibitors |
| 04/28/1994 | WO1994008933A1 Antibiotic agents |
| 04/28/1994 | WO1994008631A1 The use of carotenoporphyrins as tumor localizing agents for diagnosis, visualization and delivery of sensitizers to tumor tissues |
| 04/28/1994 | WO1994008628A1 Prevention of acetaminophen overdose toxicity with organosulfur compounds |
| 04/28/1994 | WO1994008625A1 Combination of antineoplastic agent and antisense oligonucleotides for treatment of cancer |
| 04/28/1994 | WO1994008619A1 Treatment of autoimmune and inflammatory disorders |
| 04/28/1994 | WO1994008612A1 New method of protecting central nervous system against damage resulting from cerebrovascular or neuronal compromise |
| 04/28/1994 | WO1994008609A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-α FUNCTION |
| 04/28/1994 | WO1994008606A1 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus |
| 04/28/1994 | WO1994008602A1 Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery |
| 04/28/1994 | WO1994008596A1 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it |
| 04/28/1994 | WO1994008594A1 Pharmaceutical composition containing an antimicrobial agent and an antibiotic |
| 04/28/1994 | WO1994008593A1 Method of treating lung disease with uridine triphosphates |
| 04/28/1994 | WO1994008592A1 Lyophilized cyclophosphamide compositions |
| 04/28/1994 | WO1994008591A1 Treatment for onychomycosis topically applying salicylic acid, optionally in combination with a retinoid |
| 04/28/1994 | WO1994008590A1 A method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 |
| 04/28/1994 | WO1994008589A1 Treatment of systemic lupus erythematosus with dehydroepiandrosterone |
| 04/28/1994 | WO1994008588A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof |
| 04/28/1994 | WO1994008587A1 Novel 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amines, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds |
| 04/28/1994 | WO1994008586A2 Azido derivatives of cyclopentane heptanoic or heptenoic acid |
| 04/28/1994 | WO1994008585A1 Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma |
| 04/28/1994 | WO1994008584A1 Inhibitor for metastasis of malignant tumor |
| 04/28/1994 | WO1994008583A1 Benzo-fused lactams promote release of growth hormone |
| 04/28/1994 | WO1994008580A1 Methods of combating pneumocystis carinii pneumonia and compounds useful therefor |
| 04/28/1994 | WO1994008579A1 β-AGONIST, α1-AGONIST, AND/OR α2-ANTAGONIST TREATMENT OF NEURODEGENERATIVE DISEASES AND CENTRAL NERVOUS SYSTEM TRAUMA |
| 04/28/1994 | WO1994008578A2 Tumoricidal activity of benzoquinonoid ansamycins against prostate cancer and primitive neural malignancies |
| 04/28/1994 | WO1994008577A1 Fibrinogen receptor antagonists |
| 04/28/1994 | WO1994008576A1 Taste-masking compositions of ranitidine |
| 04/28/1994 | WO1994008574A1 Treatment of cachexia and inhibition of il-6 activity |
| 04/28/1994 | WO1994008573A1 Use of a cell membrane permeant calcium buffer for reducing injury of mammalian cells in vivo |
| 04/28/1994 | WO1994008571A2 Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline ingredients, and processs for producing the same |
| 04/28/1994 | WO1994008563A1 Novel class of phosphocholine derivatives having antifungal activity |
| 04/28/1994 | WO1994008562A1 Sustained release compositions for treating periodontal disease |
| 04/28/1994 | WO1994008560A1 Ranitidine chewable tablets |
| 04/28/1994 | WO1994008548A1 Transfusion liquid-containing holder and prepared transfusion liquid |
| 04/28/1994 | WO1994008467A1 Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids |
| 04/28/1994 | WO1994008456A1 Polysubstituted benzimidazoles as antiviral agents |
| 04/28/1994 | WO1994005296A3 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 04/28/1994 | WO1994005267A3 Use of carrageenans as growth factor antagonists |
| 04/28/1994 | WO1993024640A3 Methods and compositions for in vivo gene therapy |
| 04/28/1994 | CA2147889A1 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it |
| 04/28/1994 | CA2147663A1 Combination of antineoplastic agent and antisense oligonucleotides for treatment of cancer |
| 04/28/1994 | CA2147599A1 Container filled with infusion liquids and infusion preparation |
| 04/28/1994 | CA2147352A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives and use thereof |
| 04/28/1994 | CA2147180A1 Treatment of insulin resistance in obesity linked type ii diabetes using antagonists to tnf-.alpha. function |
| 04/28/1994 | CA2147127A1 Method of inhibiting replication of hyperproliferative cells |
| 04/28/1994 | CA2147000A1 Ranitidine chewable tablets |
| 04/28/1994 | CA2146999A1 Taste-masking compositions of ranitidine |
| 04/28/1994 | CA2146990A1 Chelating polymers |
| 04/28/1994 | CA2146988A1 Treatment of cachexia and inhibition of il-6 activity |
| 04/28/1994 | CA2146962A1 Gestagenically active 19,11-bridged 4-estrenes |
| 04/28/1994 | CA2146930A1 Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists |
| 04/28/1994 | CA2146929A1 Retroviral mediated transfer of the human multiple drug resistance gene |
| 04/28/1994 | CA2146928A1 Imidazopyridine derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | CA2146923A1 Heterocyclic condensed benzoic acid derivatives as 5-ht4 receptor antagonists |
| 04/28/1994 | CA2146765A1 New taxane derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 04/28/1994 | CA2146668A1 Tumoricidal activity of benzoquinonoid ansamycins against prostate cancer and primitive neural malignancies |
| 04/28/1994 | CA2146639A1 Novel class of phosphocholine derivatives having antifungal activity |
| 04/28/1994 | CA2146569A1 Benzofuran derivatives as 5-ht1-like receptor antagonists |
| 04/28/1994 | CA2146446A1 Arginine keto-amide enzyme inhibitors |
| 04/28/1994 | CA2146261A1 Sulfonamide derivatives of benzenefused, hydroxy substituted cycloalkyl and heterocyclic ring compounds |
| 04/28/1994 | CA2146000A1 3,3-disubstituted tri-and tetracyclic indolin-2-ones useful for the treatment of cognitive disorders |
| 04/28/1994 | CA2145863A1 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus |
| 04/28/1994 | CA2145204A1 Antibiotic agents |
| 04/28/1994 | CA2144764A1 Benzo-fused lactams promote release of growth hormone |
| 04/28/1994 | CA2144763A1 Fibrinogen receptor antagonists |
| 04/28/1994 | CA2144762A1 Fibrinogen receptor antagonists |
| 04/28/1994 | CA2143193A1 N-arylheteroarylalkyl 1-phenyl-imidazol-2-one compounds for treatment of circulatory disorders |
| 04/28/1994 | CA2143192A1 N-arylheteroarylalkyl 1-cycloalkyl-imidazol-2-one compounds for treatment of circulatory disorders |
| 04/28/1994 | CA2126436A1 The use of carotenoporphyrins a tumor localizing agents for diagnosis, visualization and delivery of sensitizers to tumor tissues |
| 04/28/1994 | CA2126093A1 Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery |
| 04/27/1994 | EP0594540A1 Antiretroviral acyl compounds |
| 04/27/1994 | EP0594507A1 Use of modafinil for the treatment of urinary and fecal incontinence |
| 04/27/1994 | EP0594484A1 2-Aminopyrimidin-4-carboxamide derivatives, their preparation and their use in therapy |
| 04/27/1994 | EP0594291A1 Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor |
| 04/27/1994 | EP0594263A1 Thioalkylthio cephalosporin derivatives and intermediates |